Johnson & Johnson (JNJ) Stock Price, Quote, News & History

SPY779.87 QQQ759.84 BTC/USD84,364.00−1.38%DIA514.66 GLD381.90 TLT77.20

Johnson & Johnson (JNJ) Stock Price, Quote, News & History

JNJNYSE

Trade with Public

$255.00

0.220.09%

Last update: Oct 6, 7:23 PM

$255.00

0.220.09%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Earnings: Q3 2026 Earnings in 6 days from now on Tue Oct 13th, before the market open

Conference Call: Conference call scheduled in 6 days at 8:30 AM

Click to view the webcast

Key Statistics

Open

Volume / Avg.

0 / 7.07M

Day Range

- - -

52 Wk Range

182.94 - 281.07

Market Cap

$614.52B

P/E Ratio

29.56

Dividend Yield

2.10%

Exchange

NYSE

RSI

Short Interest

0.98%

Days to Cover

3.65

Recent Johnson & Johnson News

Johnson & Johnson Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Johnson & Johnson reports Q3 earnings Oct. 13; EPS seen at $2.48, revenue $25.31B. Analysts are mostly bullish after positive Tremfya and Carvykti data.

Avi Kapoor

Johnson & Johnson Q3 Preview: Analyst Projects In-Line Sales, Earnings Miss

Analysts expect Johnson & Johnson's Q3 FY2027 sales to be in line, but EPS to be below consensus due to IPR&D dilution.

Priya Nigam

Johnson & Johnson Clinical Trials Show Progress Across Key Therapies

Johnson & Johnson shares key clinical trial results for Tremfya in psoriatic arthritis and five-year Carvykti data in multiple myeloma.

Vandana Singh

Johnson & Johnson Drug Shows Improved Mania Symptoms in Bipolar Patients

Johnson & Johnson announces positive Phase 3 results for CAPLYTA, showing rapid reduction in bipolar I disorder manic symptoms.

Vandana Singh

Senator Bets on Small Cap Stocks Ahead of Likely Rate Hike: Why That Could be Risky

A U.S. senator has added small cap stock ETFs to his portfolio ahead of a potential Federal Reserve rate hike. Here's why the timing matters.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

27.61B

Investing Cash Flow (TTM)

-7.18B

Financing Cash Flow (TTM)

-18.54B

Free Cash Flow (TTM)

22.23B

Capital Expenditure (TTM)

-5.38B

Net Change in Cash (TTM)

1.89B

Analyst Trends and Forecast

Jun

Jul

Aug

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$642.27B

PE Ratio (TTM)

29.56

PE Ratio (FWD)

19.92

PEG Ratio (TTM)

2.67

PS Ratio (TTM)

6.35

PB Ratio (TTM)

7.23

Earnings Yield % (TTM)

3.38%

Earnings Yield % (FWD)

5.02%

EV / EBITDA (TTM)

18.91

Price / EBITDA (TTM)

18.30

Price / Free Cash Flow (TTM)

27.96

Book Value / Share

$35.26

Company Debt

Total Debt

$49.04B

LT Debt

$37.34B

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$3.01B

Total Cash

$20.42B

Debt to Equity

0.58

Issuance of Debt (TTM)

-$3.01B

Repayment of Debt (TTM)

-$19.95B

Key Statistics

Open

Volume / Avg.

0 / 7.07M

Day Range

- - -

52 Wk Range

182.94 - 281.07

Market Cap

$614.52B

P/E Ratio

29.56

Dividend Yield

2.10%

Exchange

NYSE

RSI

Short Interest

0.98%

Days to Cover

3.65

About Johnson & Johnson

Sector

Health Care

Industry

Pharmaceuticals

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy Johnson & Johnson (JNJ) stock?

You can purchase shares of Johnson & Johnson (NYSE:JNJ) through any online brokerage.

View our list of the best stock brokerages

Who are Johnson & Johnson (JNJ) competitors?

Other companies in Johnson & Johnson’s space includes: Eli Lilly and Co (NYSE:LLY), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS), AstraZeneca PLC (NYSE:AZN) and Novo Nordisk AS (NYSE:NVO).

What is the forecast, or price target, for Johnson & Johnson (JNJ) stock?

Johnson & Johnson has a consensus price target of $265.13.

What is the current price for Johnson & Johnson (JNJ)?

The stock price for Johnson & Johnson (NYSE: JNJ) is $255 last updated October 6, 2026 at 7:23 PM EDT.

Does Johnson & Johnson (JNJ) pay a dividend?

There are no upcoming dividends for Johnson & Johnson.

When is Johnson & Johnson (NYSE:JNJ) reporting earnings?

Johnson & Johnson does not have any upcoming earnings scheduled.

Is Johnson & Johnson (JNJ) going to split?

There is no upcoming split for Johnson & Johnson.

What sector and industry does Johnson & Johnson (JNJ) operate in?

Johnson & Johnson is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.